display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/adv melanoma (mML)
mML - L1 - all populationmML - L1 - BRAF wild
nivolumab alone CheckMate 067 ... CheckMate 066

Study type: